BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9

• Press Releases

  Biosplice Announces the Submission of its New Drug Application (NDA) to the FDA for Lorecivivint (LOR) to Treat Knee Osteoarthritis

  January 6, 2026

   · 

  7 min read
• Press Releases

  Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data

  January 6, 2026

   · 

  6 min read
• Press Releases

  Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition

  January 6, 2026

   · 

  11 min read
• Press Releases

  Vizient Analysis Reveals Early and Varied Drug Pricing Shifts Following Enactment of the Inflation Reduction Act

  January 6, 2026

   · 

  3 min read
• Press Releases

  Alloy Therapeutics Appoints Christian Cobaugh, Ph.D., as CEO of Alloy Genetic Medicines

  January 6, 2026

   · 

  4 min read
• Press Releases

  Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)

  January 6, 2026

   · 

  10 min read
• Press Releases

  NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer

  January 6, 2026

   · 

  12 min read
• Press Releases

  Alumis’ Envudeucitinib Delivers Leading Skin Clearance Among Next-Generation Oral Plaque Psoriasis Therapies in Phase 3 Program

  January 6, 2026

   · 

  10 min read
• Press Releases

  Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72

  January 6, 2026

   · 

  8 min read
• Press Releases

  Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026

  January 6, 2026

   · 

  11 min read